FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to experimental biology, and can be used for assessing neurological limb deficiency in experimental rats by detecting extremity performance in response to stimulation. Method consists of 5 main tests. In each of the tests the working capacity of the individual extremity of an animal is evaluated. Obtained data of five tests for an animal's left and right side are summarized separately. Value of 12 points for the left and right side corresponds to the absence of neurological deficiency of extremities. Less than 12 points for left and less than 12 for right side – presence of neurological deficiency of limbs in experimental rats.
EFFECT: method enables detecting reduced limb serviceability, minor disorders and dividing the borderline states of the neurological deficiency with higher reliability due to the developed test system, which is sensitive to degree of obtained damage and capable of catching any shifts in neurological status of animal, occurring as a result of medicinal correction, affecting cerebral plasticity.
1 cl, 3 tbl, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ASSESSMENT OF OPERABILITY OF ANTERIOR EXTREMITIES IN EXPERIMENTAL ANIMALS | 2019 |
|
RU2714479C1 |
METHOD FOR CORRECTING NEUROLOGICAL DEFICIT IN TRAUMATIC BRAIN INJURY | 2021 |
|
RU2758245C1 |
METHOD OF NEUROLOGIC DEFICIT DETECTION FOR SMALL LABORATORY ANIMALS SUFFERING FROM CEREBRAL AFFECTIONS | 2005 |
|
RU2327227C2 |
NEURORABILITATION AGENT BASED ON SODIUM 6-OXO-1-PHENYL-2-(PHENYLAMINO)-1,6-DIHYDROPYRIMIDINE-4-OLATE | 2018 |
|
RU2675694C1 |
METHOD FOR SIMULATING GLOBAL CEREBRAL ISCHEMIA IN RATS | 2014 |
|
RU2544369C1 |
KIT OF A PHARMACOLOGICAL AGENT INTENDED FOR IMPROVING THE BLOOD FLOW IN THE CEREBRAL CORTEX AND RESTORING MOTOR AND COGNITIVE FUNCTIONS OF THE BODY | 2021 |
|
RU2787479C1 |
METHOD OF SPINAL TISSUE ENGINEERING FOLLOWING ANATOMICAL RUPTURE | 2012 |
|
RU2489176C1 |
NEUROPROTECTOR | 2009 |
|
RU2406488C1 |
METHOD FOR SIMULATING BRAIN CONTUSION OF MILD DEGREE | 2019 |
|
RU2725287C1 |
AGENT POSSESSING NEUROPROTECTIVE ACTION IN ISCHEMIC CEREBRAL CIRCULATION DISORDER | 2015 |
|
RU2586301C1 |
Authors
Dates
2019-08-19—Published
2019-02-06—Filed